Detection of 14-3-3ζ in cerebrospinal fluid following experimentally evoked seizures

References

• Aitken A, Collinge DB, van Heusden BP, Isobe T, Roseboom PH, Rosenfeld G, Soll J. 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends in Biochemical Sciences 1992; 17: 498–501
   PubMed Web of Science ®Google Scholar
• Berg D, Holzmann C, Riess O. 14-3-3 proteins in the nervous system. Nature Review. Neuroscience 2003; 4: 752–762
   PubMedGoogle Scholar
• Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 2001; 56: 1528–1533
   PubMed Web of Science ®Google Scholar
• Chapman T, McKeel DW, Jr, Morris JC. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt–Jakob disease. Neurology 2000; 55: 1396–1397
   PubMedGoogle Scholar
• Cohen D, Kutluay E, Edwards J, Peltier A, Beydoun A. Sporadic Creutzfeldt–Jakob disease presenting with nonconvulsive status epilepticus. Epilepsy & Behavior 2004; 5: 792–796
   PubMed Web of Science ®Google Scholar
• Collins S, Boyd A, Fletcher A, Gonzales M, McLean CA, Byron K, Masters CL. Creutzfeldt–Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid. Journal of Clinical Neuroscience 2000; 7: 203–208
   PubMedGoogle Scholar
• DeGiorgio CM, Rabinowicz AL, Correale J, Heck CN, Gott PS, Schreiber S. Neuron-specific enolase in status epilepticus. Status epilepticus: mechanisms and management, CG Wasterlain, DM Treiman. The MIT press, Cambridge, MA 2006; 169–175
   Google Scholar
• Donmez B, Cakmur R, Men S, Oztura I, Kitis A. Coexistence of movement disorders and epilepsia partialis continua as the initial signs in probable Creutzfeldt–Jakob disease. Movement Disorders 2005; 20: 1220–1223
   PubMed Web of Science ®Google Scholar
• Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, Nishino S. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 2001; 12: 993–997
   PubMed Web of Science ®Google Scholar
• Green AJ, Thompson EJ, Stewart GE, Zeidler M, McKenzie JM, MacLeod MA, Ironside JW, Will RG, Knight RS. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt–Jakob disease. Journal of Neurology, Neurosurgery. Psychiatry 2001; 70: 744–748
   Google Scholar
• Henshall DC, Sinclair J, Simon RP. Spatio-temporal profile of DNA fragmentation and its relationship to patterns of epileptiform activity following focally evoked limbic seizures. Brain Research 2000; 858: 290–302
   PubMedGoogle Scholar
• Henshall DC, Bonislawski DP, Skradski SL, Meller R, Lan J-Q, Simon RP. Cleavage of Bid may amplify caspase-8-induced neuronal death following focally evoked limbic seizures. Neurobiology of Disease 2001; 8: 568–580
   PubMedGoogle Scholar
• Henshall DC, Araki T, Schindler CK, Shinoda S, Lan J-Q, Simon RP. Expression of death-associated protein kinase and recruitment to the tumor necrosis factor signaling pathway following brief seizures. Journal of Neurochemistry 2003; 86: 1260–1270
   PubMed Web of Science ®Google Scholar
• Henshall DC, Skradski SL, Meller R, Araki T, Minami M, Schindler CK, Lan JQ, Bonislawski DP, Simon RP. Expression and differential processing of caspases 6 and 7 in relation to specific epileptiform EEG patterns following limbic seizures. Neurobiology of Disease 2002; 10: 71–87
   PubMedGoogle Scholar
• Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. New England Journal of Medicine 1996; 335: 924–930
   PubMed Web of Science ®Google Scholar
• Kalviainen R, Salmenpera T, Partanen K, Vainio P, Riekkinen P, Pitkanen A. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology 1998; 50: 1377–1382
   PubMed Web of Science ®Google Scholar
• Lemstra AW, van Meegen MT, Vreyling JP, Meijerink PH, Jansen GH, Bulk S, Baas F, van Gool WA. 14-3-3 testing in diagnosing Creutzfeldt–Jakob disease: a prospective study in 112 patients. Neurology 2000; 55: 514–516
   PubMed Web of Science ®Google Scholar
• Liu RS, Lemieux L, Bell GS, Hammers A, Sisodiya SM, Bartlett PA, Shorvon SD, Sander JW, Duncan JS. Progressive neocortical damage in epilepsy. Annals of Neurology 2003; 53: 312–324
   PubMedGoogle Scholar
• Martinez-Yelamos A, Saiz A, Sanchez-Valle R, Casado V, Ramon JM, Graus F, Arbizu T. 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis. Neurology 2001; 57: 722–724
   PubMed Web of Science ®Google Scholar
• Mathern GW, Adelson PD, Cahan LD, Leite JP. Hippocampal neuron damage in human epilepsy: Meyer's hypothesis revisited. Progress in Brain Research 2002; 135: 237–251
   PubMed Web of Science ®Google Scholar
• Pitkanen A, Kharatishvili I, Karhunen H, Lukasiuk K, Immonen R, Nairismagi J, Grohn O, Nissinen J. Epileptogenesis in experimental models. Epilepsia 2007; 48(Suppl. 2)13–20
   PubMedGoogle Scholar
• Schindler CK, Heverin M, Henshall DC. Isoform- and subcellular fraction-specific differences in hippocampal 14-3-3 levels following experimentally evoked seizures and in human temporal lobe epilepsy. Journal of Neurochemistry 2006; 99: 561–569
   PubMedGoogle Scholar
• Schindler CK, Shinoda S, Simon RP, Henshall DC. Subcellular distribution of Bcl-2 family proteins and 14-3-3 within the rat hippocampus during seizure-induced neuronal death in the rat. Neuroscience Letters 2004; 356: 163–166
   PubMedGoogle Scholar
• Siman R, McIntosh TK, Soltesz KM, Chen Z, Neumar RW, Roberts VL. Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiology of Disease 2004; 16: 311–320
   PubMed Web of Science ®Google Scholar
• Wakabayashi H, Yano M, Tachikawa N, Oka S, Maeda M, Kido H. Increased concentrations of 14-3-3 epsilon, gamma and zeta isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction. Clinica Chimica Acta 2001; 312: 97–105
   PubMed Web of Science ®Google Scholar
• Wiltfang J, Otto M, Baxter HC, Bodemer M, Steinacker P, Bahn E, Zerr I, Kornhuber J, Kretzschmar HA, Poser S, Ruther E, Aitken A. Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt–Jakob disease. Journal of Neurochemistry 1999; 73: 2485–2490
   PubMed Web of Science ®Google Scholar
• Zanusso G, Fiorini M, Farinazzo A, Gelati M, Benedetti MD, Ferrari S, Dalla Libera A, Capaldi S, Monaco HL, Rizzuto N, Monaco S. Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients. Neurology 2005; 64: 1618–1620
   PubMed Web of Science ®Google Scholar